Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00754832 · ClinicalTrials.gov registry record · Phase 2
American Ginseng Treatment for Multiple Sclerosis Related Fatigue
A Phase 2 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 2
- Development phase
- 56
- Enrollment target
NCT00754832 is a Phase 2 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 56 participants.
The verdict
NCT00754832, a Phase 2 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 56 participants
- Enrollment target
Study Summary
This research project will determine the safety and tolerability of ginseng in subjects with MS and will gather preliminary data on the efficacy of ginseng vs placebo for the treatment of MS fatigue.
Interventions
- DRUG placebo
- DRUG American ginseng extract HT-1001
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2005-09 |
| Est. Completion | 2011-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00754832
The ClinicalTrials.gov registry entry for NCT00754832 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00754832 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00754832 about?
NCT00754832 is a clinical study titled "American Ginseng Treatment for Multiple Sclerosis Related Fatigue". This research project will determine the safety and tolerability of ginseng in subjects with MS and will gather preliminary data on the efficacy of ginseng vs placebo for the treatment of MS fatigue.
What is the current status of trial NCT00754832?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 56 participants. The study started on 2005-09. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00754832?
The interventions under investigation include: placebo (DRUG), American ginseng extract HT-1001 (DRUG).
Who is sponsoring clinical trial NCT00754832?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.